Live
- World Tuna Day 2024: Understanding the Theme, History, Significance, Facts, and Quotes
- TDP Files Petition in High Court Over EC Decision on Jana Sena Glass Tumbler Symbol
- Varuthini Ekadashi 2024: Date, parana time, puja rituals, history and significance
- OU hostels row: BRS files complaint with CEO against Revanth
- Hebah’s latest fashion statement turns heads
- Satyadev’s ‘Krishnamma’ trailer promises a gripping tale of revenge
- HC suspends VS Sirpurkar panel report on ‘Disha’ encounter until further orders
- Koratala Siva hints about updates on NTR’s ‘Devara’
- Naveen Chandra clinches Best Actor Award at Dada Saheb Phalke Film Festival
- What to not cook in an iron kadhai
Cipla receives USFDA nod for a generic version of Brovana
Cipla receives USFDA nod for a generic version of Brovana
Drug major Cipla Limited on Wednesday, June 23, 2021, announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Arformoterol Tartrate Inhalation Solution from the United States Food and Drug Administration (US FDA).
Drug major Cipla Limited on Wednesday, June 23, 2021, announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Arformoterol Tartrate Inhalation Solution from the United States Food and Drug Administration (US FDA).
Cipla's Arformoterol Tartrate Inhalation Solution 15 mcg / 2 mL is an AN-rated generic therapeutic equivalent version of Sunovion Pharmaceuticals Inc.'s Brovana.
Brovana is a long-acting beta-2 adrenergic agonist (beta-2 agonist) indicated for:
• Long-term, twice daily (morning and evening) administration in the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
• According to IQVIA (IMS Health), Brovana had US sales of approximately $438M for the 12-month period ending April 2021.
Cipla in a regulatory filing said, "Cipla receives final approval for a generic version of Sunovion Pharmaceuticals, Inc.'s Brovana® (Arformoterol Tartrate Inhalation Solution 15 mcg/ 2mL) from the United States Food and Drug Administration (US FDA)."
The product is available for shipping immediately.
